Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

Targeting DCAF5 restores p53 tumor suppressor function and exerts anti-leukemic effects in AML

Ping Wang, Jishi Wang

Blood (2025) 146 (Supplement 1): 5011.

https://doi.org/10.1182/blood-2025-5011

Published: 2025

Journal Articles

Detection of CPC in peripheral blood after G-CSF mobilization reduces the contamination rate of autologous transplantation stem cell collections for multiple myeloma and explore strategies for graft purification treatment

Ping Wang, Xi Zhang, Xixi Xiang, Xiaojuan Deng, Yuxuan Du, Yi Li, Xiangui Peng

Blood (2025) 146 (Supplement 1): 4183.

https://doi.org/10.1182/blood-2025-4183

Published: 2025

Journal Articles

Prognostic implications of measurable residual disease and autologous hematopoietic stem cell transplantation in primary plasma cell leukemia in the era of novel agents

Qiling Bu, Yiwen Jiang, Jingjing Deng, Ping Wang, Zhiyao Zhang, Guangzhong Yang, Ying Tian, Wen Gao, Aijun Liu, Leng Yun, Yin Wu, Wenming Chen, Honghu Zhu

Blood (2025) 146 (Supplement 1): 7564.

https://doi.org/10.1182/blood-2025-7564

Published: 2025

Journal Articles

Efficacy and safety of zanubrutinib-containing regimens in patients with newly diagnosed Mantle Cell Lymphoma: Interim results from a Phase II investigator-initiated study

Blood (2025) 146 (Supplement 1): 1823.

https://doi.org/10.1182/blood-2025-1823

Published: 2025

Journal Articles

A real-world study on first-line early switch to kpd regimen in the treatment of multiple myeloma patients with suboptimal induction efficacy or intolerance

xu Ji, Yanliang Bai, jiangxue Hou, tao Liu, ping Wang, sun Wu, weiling Qin, chao Li, junjie Yin, genjie Wang, zheng Xu, shuhao mei, guochao Ji, Wenyi Lu, Baijun Fang, quande Lin

Blood (2025) 146 (Supplement 1): 7548.

https://doi.org/10.1182/blood-2025-7548

Published: 2025

Journal Articles

Chimeric antigen receptor (CAR) T-cell persistence at month 3 predicts clinical outcomes in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) treated with obecabtagene autoleucel (obe-cel)

Claire Roddie, Jae Park, Eleni Tholouli, Karamjeet Sandhu, Paul Shaughnessy, Pere Barba, Manuel Guerreiro, Deborah Yallop, Aaron Logan, Mehrdad Abedi, Pierre Lao-Sirieix, Ping Wang, Wolfram Brugger, Bijal Shah, Anthony Hunter, Daniel Deangelo, Elias Jabbour

Blood (2025) 146 (Supplement 1): 5118.

https://doi.org/10.1182/blood-2025-5118

Published: 2025

Journal Articles

Impact of chimeric antigen receptor (CAR) product cell phenotypes on clinical outcomes following treatment with obecabtagene autoleucel (obe-cel)

Benjamin Simpson, Rehan Hussain, Mohammed Banani, Karamjeet Sandhu, Michael Bishop, Aaron Logan, Ping Wang, William Day, Claire Roddie, Pierre Lao-Sirieix

Blood (2025) 146 (Supplement 1): 33.

https://doi.org/10.1182/blood-2025-33

Published: 2025

Journal Articles

Precision targeting of pathogenic B cells and autoantibodies in systemic lupus erythematosus using CAR T cells against the IGHV4-34 B cell receptor

Blood (2025) 146 (Supplement 1): 4120.

https://doi.org/10.1182/blood-2025-4120

Published: 2025

Journal Articles

Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy

Blood (2024) 143 (2): 139–151.

https://doi.org/10.1182/blood.2022018658

Published: 2024

Includes: Supplemental data

Journal Articles

Selective PI3Kδ Inhibitor Parsaclisib Combined with HDAC Inhibitor Chidamide in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma: Preliminary Results of a Phase Ib/Ⅱ Study

Zheng Yan, Shuna Yao, Shuang Zhao, Haiying Wang, Junfeng Chu, Yuanlin Xu, Jiuyang Zhang, Lina Zhang, Quande Lin, Lijie Liang, Ping Wang, Wenyong Li, Xiaolu Teng, Zhihua Yao, Yanyan Liu

Blood (2023) 142 (Supplement 1): 3075.

https://doi.org/10.1182/blood-2023-185902

Published: 2023

Journal Articles

Precision Targeting of the Malignant Clone in Diffuse Large B Cell Lymphoma Using Chimeric Antigen Receptor T Cells Against the Clonotypic IGHV4-34 B Cell Receptor

Ivan J Cohen, Audrey C Bochi-Layec, Ki Hyun Kim, Scott Jenks, Ositadimma Ugwuanyi, Guido Ghilardi, Giulia Gabrielli, Jaryse Harris, Li-Ping Wang, Yunlin Zhang, Raymone Pajarillo, Elisavet Vlachonikola, Patrizia Porazzi, Ignacio Sanz, Paolo Ghia, Kostas Stamatopoulos, Stephen J Schuster, Marco Ruella

Blood (2023) 142 (Supplement 1): 1020.

https://doi.org/10.1182/blood-2023-187618

Published: 2023

Journal Articles

Identification of a Novel FAM135B Cancer Susceptibility Mutation in a Family with Multiple Cases of MLL -Rearranged AML

Li-li PAN, Yanling Sun, Xiaolin Lai, Luya Ye, Xue-chun Wang, Zhi-xiang Chen, Yuanhua Cai, Yi Zheng, Yang Li, Ya-ping Wang, Xin Liu, Shao-yuan Wang, Qian-fei Wang

Blood (2022) 140 (Supplement 1): 9107.

https://doi.org/10.1182/blood-2022-165170

Published: 2022

Journal Articles

Neutrophils promote clearance of nuclear debris following acid-induced lung injury

Joseph H. Oved, Andrew J. Paris, Kandace Gollomp, Ning Dai, Kathryn Rubey, Ping Wang, Lynn A. Spruce, Steven H. Seeholzer, Mortimer Poncz, G. Scott Worthen

Blood (2021) 137 (3): 392–397.

https://doi.org/10.1182/blood.2020005505

Published: 2021

Includes: Multimedia, Supplemental data

Journal Articles

PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation

Blood (2019) 134 (14): 1176–1189.

https://doi.org/10.1182/blood.2019000578

Published: 2019

Includes: Supplemental data

Journal Articles

Role of HO-1 in B Lymphocyte Proliferation and Development in Mice

Jishi Wang, Dan Ma, MD, Zhengyu Yu, Ping Wang, Zhen Zhou, Qin Fang, Sishi Tang, Zhengchang He, Ping Liu

Blood (2017) 130 (Supplement 1): 1012.

https://doi.org/10.1182/blood.V130.Suppl_1.1012.1012

Published: 2017

Journal Articles

PML-Rara Drives Acute Promyelocytic Leukemia Genesis By Enhanceosome Depletion Leading to 3D Chromatin Reorganization

Ping Wang, MD Ph. D;, Zhonghui Tang, Ph. D., Hui Zhang, MD, PhD, Yijun Ruan, Ph. D.

Blood (2016) 128 (22): 1554.

https://doi.org/10.1182/blood.V128.22.1554.1554

Published: 2016

Journal Articles

Adequate Use of the 4T´s Score As a Primary Screening Tool for Heparin Induced Thrombocytopenia

Ilana Miriam Schlam, MD, Eithan Orlev-Shitrit, MD, Chelsea Beaton, Ping Wang, Charles Glueck, MD, Miguel Islas-Ohlmayer, MD

Blood (2016) 128 (22): 5911.

https://doi.org/10.1182/blood.V128.22.5911.5911

Published: 2016

Journal Articles

Epigenetic Reprogramming of Cis-Regulatory Sites By R882 -Mutated DNMT3A Potentiates Aberrant Stem Cell Gene Program and Acute Leukemia Development

Rui Lu, PhD, Ping Wang, PhD, Trevor Parton, Deyou Zheng, PhD, Gang Greg Wang, PhD

Blood (2015) 126 (23): 2430.

https://doi.org/10.1182/blood.V126.23.2430.2430

Published: 2015

Journal Articles

Microrna-17~92 Cluster Upregulates NF-KB Activity Via Suppressing Multiple NF-KB Negative Regulators Mediating Ubiquitination

Xianhuo Wang, MD, Huaqing Wang, Chengfeng Bi, Xiaoyan Zhang, Xin Huang, Xuan Zhang, Javeed Iqbal, George W Wright, Louis M Staudt, Wing C Chan, Timothy W McKeithan, Ping Wang, Huilai Zhang, Kai Fu, MD PhD

Blood (2015) 126 (23): 3638.

https://doi.org/10.1182/blood.V126.23.3638.3638

Published: 2015

Journal Articles

Potential Crosstalk of Interleukin-6-Heme Oxygenase-1 Dependent Mechanism Involved in Resistance to Lenalidomide in Multiple Myeloma Cells

Jishi Wang, MD, Weibing Wu, Dan Ma, MD, Ping Wang, Lu Cao, Qin Fang, Jiangyuan Zhao, Tangsheng Lu

Blood (2015) 126 (23): 4856.

https://doi.org/10.1182/blood.V126.23.4856.4856

Published: 2015

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Targeting DCAF5 restores p53 tumor suppressor function and exerts anti-leukemic effects in AML

Detection of CPC in peripheral blood after G-CSF mobilization reduces the contamination rate of autologous transplantation stem cell collections for multiple myeloma and explore strategies for graft purification treatment

Prognostic implications of measurable residual disease and autologous hematopoietic stem cell transplantation in primary plasma cell leukemia in the era of novel agents

Efficacy and safety of zanubrutinib-containing regimens in patients with newly diagnosed Mantle Cell Lymphoma: Interim results from a Phase II investigator-initiated study

A real-world study on first-line early switch to kpd regimen in the treatment of multiple myeloma patients with suboptimal induction efficacy or intolerance

Chimeric antigen receptor (CAR) T-cell persistence at month 3 predicts clinical outcomes in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) treated with obecabtagene autoleucel (obe-cel)

Impact of chimeric antigen receptor (CAR) product cell phenotypes on clinical outcomes following treatment with obecabtagene autoleucel (obe-cel)

Precision targeting of pathogenic B cells and autoantibodies in systemic lupus erythematosus using CAR T cells against the IGHV4-34 B cell receptor

Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy

Selective PI3Kδ Inhibitor Parsaclisib Combined with HDAC Inhibitor Chidamide in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma: Preliminary Results of a Phase Ib/Ⅱ Study

Precision Targeting of the Malignant Clone in Diffuse Large B Cell Lymphoma Using Chimeric Antigen Receptor T Cells Against the Clonotypic IGHV4-34 B Cell Receptor

Identification of a Novel FAM135B Cancer Susceptibility Mutation in a Family with Multiple Cases of MLL -Rearranged AML

Neutrophils promote clearance of nuclear debris following acid-induced lung injury

PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation

Role of HO-1 in B Lymphocyte Proliferation and Development in Mice

PML-Rara Drives Acute Promyelocytic Leukemia Genesis By Enhanceosome Depletion Leading to 3D Chromatin Reorganization

Adequate Use of the 4T´s Score As a Primary Screening Tool for Heparin Induced Thrombocytopenia

Epigenetic Reprogramming of Cis-Regulatory Sites By R882 -Mutated DNMT3A Potentiates Aberrant Stem Cell Gene Program and Acute Leukemia Development

Microrna-17~92 Cluster Upregulates NF-KB Activity Via Suppressing Multiple NF-KB Negative Regulators Mediating Ubiquitination

Potential Crosstalk of Interleukin-6-Heme Oxygenase-1 Dependent Mechanism Involved in Resistance to Lenalidomide in Multiple Myeloma Cells

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only